"We are pleased with Coloplast's performance," says Sten Scheibye, President and CEO. "We are reporting a decent operating profit and expect the slight slowdown of our organic growth to be tem-porary. January's sales growth seems to confirm that. The integration of the acquired urology busi-ness is proceeding well and we retain our previously announced forecast for the full year."
Attachments
